Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Neuropharmacology. 2010 Jul 16;59(6):492–502. doi: 10.1016/j.neuropharm.2010.07.004

Figure 5.

Figure 5

Effects of ciproxifan and MK-801 on PPI after presentation of a 5 dB (left graph), 10 dB (middle graph), and 15 dB prepulse auditory stimulus (right graph). Symbols indicate significant differences within each of the three ciproxifan pretreatment groups at each intensity – an asterisk (*) indicates a significant difference from saline treatment and a cross (+) indicates a significant difference from saline and MK-801 (0.05 mg/kg) treatments. Group differences refer to outcomes of post-hoc comparisons that were significant at p ≤ .05 (Fishers PLSD) and are indicated by connecting lines. Data represent average % of PPI (see text for further definition) ± s.e.m during prepulse inhibition trials. n = 12 rats per group.